RP-3500 and Olaparib in DNA Damage Repair Pathway Deficient Relapsed/Refractory Chronic Lymphocytic Leukemia
Clinical trial NCT05405309 · TERMINATED
Trial details
- NCT number
- NCT05405309
- Sponsor
- University of Utah
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-23
- Primary completion
- 2023-10-24
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.